{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T15:40:26Z","timestamp":1783698026114,"version":"3.55.0"},"reference-count":50,"publisher":"Walter de Gruyter GmbH","issue":"6","license":[{"start":{"date-parts":[[2012,9,5]],"date-time":"2012-09-05T00:00:00Z","timestamp":1346803200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch. Immunol. Ther. Exp."],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1007\/s00005-012-0195-9","type":"journal-article","created":{"date-parts":[[2012,9,4]],"date-time":"2012-09-04T10:27:41Z","timestamp":1346754461000},"page":"461-468","source":"Crossref","is-referenced-by-count":14,"title":["Putative Biological Mechanisms of Efficiency of Substrate Reduction Therapies for Mucopolysaccharidoses"],"prefix":"10.2478","volume":"60","author":[{"given":"Zyta","family":"Banecka-Majkutewicz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Jak\u00f3bkiewicz-Banecka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Gabig-Cimi\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicja","family":"W\u0119grzyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grzegorz","family":"W\u0119grzyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2012,9,5]]},"reference":[{"key":"195_CR1","doi-asserted-by":"crossref","first-page":"132","DOI":"10.2174\/156652311794940791","volume":"11","author":"DS Anson","year":"2011","unstructured":"Anson DS, McIntyre C, Byers S (2011) Therapies for neurological disease in the mucopolysaccharidoses. Curr Gene Ther 11:132\u2013143","journal-title":"Curr Gene Ther"},{"key":"195_CR2","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s10545-009-9029-2","volume":"33","author":"A Arfi","year":"2010","unstructured":"Arfi A, Richard M, Gandolphe C, Scherman D (2010) Storage correction in cells of patients suffering from mucopolysaccharidoses types IIIA and VII after treatment with genistein and other isoflavones. J Inherit Metab Dis 33:61\u201367","journal-title":"J Inherit Metab Dis"},{"key":"195_CR3","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/iub.284","volume":"62","author":"M Beck","year":"2010","unstructured":"Beck M (2010) Therapy for lysosomal storage disorders. IUBMB Life 62:33\u201340","journal-title":"IUBMB Life"},{"key":"195_CR4","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1469-8749.1972.tb02557.x","volume":"14","author":"PF Benson","year":"1972","unstructured":"Benson PF, Dean MF, Muir H (1972) A form of mucopolysaccharidosis with visceral storage and excessive urinary excretion of chondroitin sulphate. Dev Med Child Neurol 14:69\u201374","journal-title":"Dev Med Child Neurol"},{"key":"195_CR5","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0005-8165(77)80006-1","volume":"160","author":"H Cain","year":"1977","unstructured":"Cain H, Egner E, Kresse H (1977) Mucopolysaccharidosis III A (Sanfilippo disease type A). Histochemical, electron microscopical and biochemical findings. Beitr Pathol 160:58\u201372","journal-title":"Beitr Pathol"},{"key":"195_CR6","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1517\/14656566.9.2.311","volume":"9","author":"LA Clarke","year":"2008","unstructured":"Clarke LA (2008) Idursulfase for the treatment of mucopolysaccharidosis II. Expert Opin Pharmacother 9:311\u2013317","journal-title":"Expert Opin Pharmacother"},{"key":"195_CR7","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1177\/0192623307309925","volume":"36","author":"AP Cotrim","year":"2008","unstructured":"Cotrim AP, Baum BJ (2008) Gene therapy: some history, applications, problems, and prospects. Toxicol Pathol 36:97\u2013103","journal-title":"Toxicol Pathol"},{"key":"195_CR8","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1750-1172-6-55","volume":"6","author":"MH Ru de","year":"2011","unstructured":"de Ru MH, Boelens JJ, Das AM, Jones SA, van der Lee JH, Mahlaoui N, Mengel E, Offringa M, O\u2019Meara A, Parini R, Rovelli A, Sykora KW, Valayannopoulos V, Vellodi A, Wynn RF, Wijburg FA (2011) Enzyme replacement therapy and\/or hematopoietic stem cell transplantation at diagnosis in patients with mucopolysaccharidosis type I: results of a European consensus procedure. Orphanet J Rare Dis 6:55","journal-title":"Orphanet J Rare Dis"},{"key":"195_CR9","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/ana.22643","volume":"71","author":"JVM Ruijter de","year":"2012","unstructured":"de Ruijter JVM, Valstar MJ, Narajczyk M, Wegrzyn G, Kulik W, Ijlst L, Wagemans T, van der Wal WM, Wijburg FA (2012) Genistein in Sanfilippo disease: a randomized controlled cross-over trial. Ann Neurol 71:110\u2013120","journal-title":"Ann Neurol"},{"key":"195_CR10","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1007\/s10545-011-9342-4","volume":"34","author":"V Delgadillo","year":"2011","unstructured":"Delgadillo V, O\u2019Callaghan Mdel M, Artuch R, Montero R, Pineda M (2011) Genistein supplementation in patients affected by Sanfilippo disease. J Inherit Metab Dis 34:1039\u20131044","journal-title":"J Inherit Metab Dis"},{"issue":"Suppl 1","key":"195_CR11","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0006-3495(64)86935-6","volume":"4","author":"A Dorfman","year":"1964","unstructured":"Dorfman A (1964) Metabolism of acid mucopolysaccharides. Biophys J 4(Suppl 1):155\u2013165","journal-title":"Biophys J"},{"key":"195_CR12","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/ejhg.2009.144","volume":"18","author":"D Dziedzic","year":"2010","unstructured":"Dziedzic D, Wegrzyn G, Jakobkiewicz-Banecka J (2010) Impairment of glycosaminoglycan synthesis in mucopolysaccharidosis type IIIA cells by using siRNA: a potential therapeutic approach for Sanfilippo disease. Eur J Hum Genet 18:200\u2013205","journal-title":"Eur J Hum Genet"},{"key":"195_CR13","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1023\/B:BOLI.0000045756.54006.17","volume":"27","author":"D Elstein","year":"2004","unstructured":"Elstein D, Hollak C, Aerts JM, van Weely S, Maas M, Cox TM, Lachmann RH, Hrebicek M, Platt FM, Butters TD, Dwek RA, Zimran A (2004) Sustained therapeutic effects of oral miglustat (Zavesca, N-butyldeoxynojirimycin, OGT 918) in type I Gaucher disease. J Inherit Metab Dis 27:757\u2013766","journal-title":"J Inherit Metab Dis"},{"key":"195_CR14","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1111\/j.1476-5381.2009.00565.x","volume":"159","author":"A Friso","year":"2010","unstructured":"Friso A, Tomanin R, Salvalaio M, Scarpa M (2010) Genistein reduces glycosaminoglycan levels in a mouse model of mucopolysaccharidosis type II. Br J Pharmacol 159:1082\u20131091","journal-title":"Br J Pharmacol"},{"key":"195_CR15","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.tibs.2009.06.005","volume":"34","author":"L Fux","year":"2009","unstructured":"Fux L, Ilan N, Sanderson RD, Vlodavsky I (2009) Heparanase: busy at the cell surface. Trends Biochem Sci 34:511\u2013519","journal-title":"Trends Biochem Sci"},{"key":"195_CR16","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/BF03195237","volume":"48","author":"J Jakobkiewicz-Banecka","year":"2007","unstructured":"Jakobkiewicz-Banecka J, Wegrzyn A, Wegrzyn G (2007) Substrate deprivation therapy: a new hope for patients suffering from neuronopathic forms of inherited lysosomal storage diseases. J Appl Genet 48:383\u2013388","journal-title":"J Appl Genet"},{"key":"195_CR17","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1423-0127-16-26","volume":"16","author":"J Jakobkiewicz-Banecka","year":"2009","unstructured":"Jakobkiewicz-Banecka J, Piotrowska E, Narajczyk M, Baranska S, Wegrzyn G (2009) Genistein-mediated inhibition of glycosaminoglycan synthesis, which corrects storage in cells of patients suffering from mucopolysaccharidoses, acts by influencing an epidermal growth factor-dependent pathway. J Biomed Sci 16:26","journal-title":"J Biomed Sci"},{"key":"195_CR18","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.2174\/138920111798376932","volume":"12","author":"J Jakobkiewicz-Banecka","year":"2011","unstructured":"Jakobkiewicz-Banecka J, Piotrowska E, Gabig-Ciminska M et al (2011) Substrate reduction therapies for mucopolysaccharidoses. Curr Pharm Biotechnol 12:1860\u20131865","journal-title":"Curr Pharm Biotechnol"},{"key":"195_CR19","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/ejhg.2009.143","volume":"18","author":"X Kaidonis","year":"2010","unstructured":"Kaidonis X, Liaw WC, Roberts AD, Ly M, Anson D, Byers S (2010) Gene silencing of EXTL2 and EXTL3 as a substrate deprivation therapy for heparan sulphate storing mucopolysaccharidoses. Eur J Hum Genet 18:194\u2013199","journal-title":"Eur J Hum Genet"},{"key":"195_CR20","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/ajmg.a.31021","volume":"139","author":"A Kloska","year":"2005","unstructured":"Kloska A, Bohdanowicz J, Konopa G et al (2005) Changes in hair morphology of mucopolysaccharidosis I patients treated with recombinant human alpha-l-iduronidase (laronidase, Aldurazyme). Am J Med Genet A 139:199\u2013203","journal-title":"Am J Med Genet A"},{"key":"195_CR21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11011-011-9233-2","volume":"26","author":"A Kloska","year":"2011","unstructured":"Kloska A, Jakobkiewicz-Banecka J, Narajczyk M, Banecka-Majkutewicz Z, Wegrzyn G (2011) Effects of flavonoids on glycosaminoglycan synthesis: implications for substrate reduction therapy in Sanfilippo disease and other mucopolysaccharidoses. Metab Brain Dis 26:1\u20138","journal-title":"Metab Brain Dis"},{"key":"195_CR22","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.expneurol.2010.07.024","volume":"225","author":"AA Lau","year":"2010","unstructured":"Lau AA, Hannouche H, Rozaklis T, Hassiotis S, Hopwood JJ, Hemsley KM (2010) Allogeneic stem cell transplantation does not improve neurological deficits in mucopolysaccharidosis type IIIA mice. Exp Neurol 225:445\u2013454","journal-title":"Exp Neurol"},{"key":"195_CR23","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3109\/03009734.2011.641609","volume":"117","author":"M Machaczka","year":"2012","unstructured":"Machaczka M, Hast R, Dahlman I, Lerner R, Klimkowska M, Engvall M, H\u00e4gglund H (2012) Substrate reduction therapy with miglustat for type 1 Gaucher disease: a retrospective analysis from a single institution. Ups J Med Sci 117:28\u201334","journal-title":"Ups J Med Sci"},{"key":"195_CR24","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/8904_2011_87","volume":"5","author":"V Malinova","year":"2012","unstructured":"Malinova V, W\u0119grzyn G, Narajczyk M (2012) The use of elevated doses of genistein-rich soy extract in the gene expression-targeted isoflavone therapy (GET IT) for Sanfilippo disease patients. JIMD Rep 5:21\u201325","journal-title":"JIMD Rep"},{"key":"195_CR25","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s00431-007-0462-7","volume":"167","author":"M Malinowska","year":"2008","unstructured":"Malinowska M, Jakobkiewicz-Banecka J, Kloska A et al (2008) Abnormalities in the hair morphology of patients with some but not all types of mucopolysaccharidoses. Eur J Pediatr 167:203\u2013209","journal-title":"Eur J Pediatr"},{"key":"195_CR26","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ymgme.2009.06.013","volume":"98","author":"M Malinowska","year":"2009","unstructured":"Malinowska M, Wilkinson FL, Bennett W et al (2009) Genistein reduces lysosomal storage in peripheral tissues of mucopolysaccharide IIIB mice. Mol Genet Metab 98:235\u2013242","journal-title":"Mol Genet Metab"},{"key":"195_CR27","doi-asserted-by":"crossref","first-page":"e14192","DOI":"10.1371\/journal.pone.0014192","volume":"5","author":"M Malinowska","year":"2010","unstructured":"Malinowska M, Wilkinson FL, Langford-Smith KJ et al (2010) Genistein improves neuropathology and corrects behaviour in a mouse model of neurodegenerative metabolic disease. PLoS ONE 5:e14192","journal-title":"PLoS ONE"},{"key":"195_CR28","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1002\/ajmg.a.34146","volume":"155","author":"J Marucha","year":"2011","unstructured":"Marucha J, Tylki-Szymanska A, Jakobkiewicz-Banecka J et al (2011) Improvement in the range of joint motion in seven patients with mucopolysaccharidosis type II during experimental gene expression-targeted isoflavone therapy (GET IT). Am J Med Genet A 155:2257\u20132262","journal-title":"Am J Med Genet A"},{"key":"195_CR29","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1002\/ajmg.a.32294","volume":"146","author":"MV Munoz-Rojas","year":"2008","unstructured":"Munoz-Rojas MV, Vieira T, Costa R, Fagondes S, John A, Jardim LB, Vedolin LM, Raymundo M, Dickson PI, Kakkis E, Giugliani R (2008) Intrathecal enzyme replacement therapy in a patient with mucopolysaccharidosis type I and symptomatic spinal cord compression. Am J Med Genet A 146:2538\u20132544","journal-title":"Am J Med Genet A"},{"key":"195_CR30","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.ymgme.2009.11.008","volume":"99","author":"MV Munoz-Rojas","year":"2010","unstructured":"Munoz-Rojas MV, Horovitz DD, Jardim LB, Raymundo M, Llerena JC Jr, de Magalh\u00e3es Tde S, Vieira TA, Costa R, Kakkis E, Giugliani R (2010) Intrathecal administration of recombinant human N-acetylgalactosamine 4-sulfatase to a MPS VI patient with pachymeningitis cervicalis. Mol Genet Metab 99:346\u2013350","journal-title":"Mol Genet Metab"},{"key":"195_CR31","first-page":"3421","volume-title":"The metabolic and molecular bases of inherited disease","author":"EF Neufeld","year":"2001","unstructured":"Neufeld EF, Muenzer J (2001) The mucopolysaccharidoses. In: Scriver CR et al (eds) The metabolic and molecular bases of inherited disease, vol III. McGraw-Hill, New York, pp 3421\u20133452"},{"key":"195_CR32","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.clinthera.2005.08.004","volume":"27","author":"GM Pastores","year":"2005","unstructured":"Pastores GM, Barnett NL, Kolodny EH (2005) An open-label, noncomparative study of miglustat in type I Gaucher disease: efficacy and tolerability over 24\u00a0months of treatment. Clin Ther 27:1215\u20131227","journal-title":"Clin Ther"},{"key":"195_CR33","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S1474-4422(07)70194-1","volume":"6","author":"MC Patterson","year":"2007","unstructured":"Patterson MC, Vecchio D, Prady H, Abel L, Wraith JE (2007) Miglustat for treatment of Niemann-Pick C disease: a randomised controlled study. Lancet Neurol 6:765\u2013772","journal-title":"Lancet Neurol"},{"key":"195_CR34","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/sj.ejhg.5201623","volume":"14","author":"E Piotrowska","year":"2006","unstructured":"Piotrowska E, Jakobkiewicz-Banecka J, Baranska S et al (2006) Genistein-mediated inhibition of glycosaminoglycan synthesis as a basis for gene expression-targeted isoflavone therapy for mucopolysaccharidoses. Eur J Hum Genet 14:846\u2013852","journal-title":"Eur J Hum Genet"},{"key":"195_CR35","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.curtheres.2008.04.002","volume":"69","author":"E Piotrowska","year":"2008","unstructured":"Piotrowska E, Jak\u00f3bkiewicz-Banecka J, Tylki-Szyma\u0144ska A et al (2008) The use of genistin-rich isoflavone extract in substrate reduction therapy for Sanfilippo disease: open-label, pilot study in 10 pediatric patients. Curr Ther Res 69:166\u2013179","journal-title":"Curr Ther Res"},{"issue":"Suppl 1","key":"195_CR36","doi-asserted-by":"crossref","first-page":"S109","DOI":"10.1002\/ptr.2944","volume":"24","author":"E Piotrowska","year":"2010","unstructured":"Piotrowska E, Jakobkiewicz-Banecka J, Wegrzyn G (2010) Different amounts of isoflavones in various commercially available soy extracts in the light of gene expression-targeted isoflavone therapy. Phytother Res 24(Suppl 1):S109\u2013S113","journal-title":"Phytother Res"},{"key":"195_CR37","doi-asserted-by":"crossref","first-page":"CR196","DOI":"10.12659\/MSM.881715","volume":"17","author":"E Piotrowska","year":"2011","unstructured":"Piotrowska E, Jakobkiewicz-Banecka J, Maryniak A et al (2011) Two-year follow-up of Sanfilippo Disease patients treated with a genistein-rich isoflavone extract: assessment of effects on cognitive functions and general status of patients. Med Sci Monit 17:CR196\u2013CR202","journal-title":"Med Sci Monit"},{"key":"195_CR38","first-page":"2686","volume":"118","author":"KP Ponder","year":"2008","unstructured":"Ponder KP (2008) Immune response hinders therapy for lysosomal storage diseases. J Clin Invest 118:2686\u20132689","journal-title":"J Clin Invest"},{"key":"195_CR39","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1053\/j.seminhematol.2009.10.008","volume":"47","author":"VK Prasad","year":"2010","unstructured":"Prasad VK, Kurtzberg J (2010) Transplant outcomes in mucopolysaccharidoses. Semin Hematol 47:59\u201369","journal-title":"Semin Hematol"},{"key":"195_CR40","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1203\/01.pdr.0000233037.00707.da","volume":"60","author":"AL Roberts","year":"2006","unstructured":"Roberts AL, Thomas BJ, Wilkinson AS, Fletcher JM, Byers S (2006) Inhibition of glycosaminoglycan synthesis using rhodamine B in a mouse model of mucopolysaccharidosis type IIIA. Pediatr Res 60:309\u2013314","journal-title":"Pediatr Res"},{"key":"195_CR41","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ymgme.2007.06.016","volume":"92","author":"AL Roberts","year":"2007","unstructured":"Roberts AL, Rees MH, Klebe S, Fletcher JM, Byers S (2007) Improvement in behaviour after substrate deprivation therapy with rhodamine B in a mouse model of MPS IIIA. Mol Genet Metab 92:115\u2013121","journal-title":"Mol Genet Metab"},{"key":"195_CR42","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.tins.2011.05.006","volume":"34","author":"ML Schultz","year":"2011","unstructured":"Schultz ML, Tecedor L, Chang M, Davidson BL (2011) Clarifying lysosomal storage diseases. Trends Neurosci 34:401\u2013410","journal-title":"Trends Neurosci"},{"key":"195_CR43","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.ymgme.2011.09.010","volume":"104","author":"A Tylki-Szyma\u0144ska","year":"2011","unstructured":"Tylki-Szyma\u0144ska A, Groener JE, Kami\u0144ski ML, \u0141ugowska A, Jurkiewicz E, Czartoryska B (2011) Gaucher disease due to saposin C deficiency, previously described as non-neuronopathic form\u2014no positive effects after 2-years of miglustat therapy. Mol Genet Metab 104:627\u2013630","journal-title":"Mol Genet Metab"},{"key":"195_CR44","first-page":"211","volume":"39","author":"JJ Gemund Van","year":"1971","unstructured":"Van Gemund JJ, Daems WT, Vio PA, Giesberts MA (1971) Electron microscopy of intestinal suction-biopsy specimens as an aid in the diagnosis of mucopolysaccharidoses and other lysosomal storage diseases. Maandschr Kindergeneeskd 39:211\u2013217","journal-title":"Maandschr Kindergeneeskd"},{"key":"195_CR45","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/iub.1007","volume":"64","author":"A Wegrzyn","year":"2012","unstructured":"Wegrzyn A (2012) Gene expression-targeted isoflavone therapy. IUBMB Life 64:307\u2013315","journal-title":"IUBMB Life"},{"key":"195_CR46","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.mehy.2003.12.027","volume":"62","author":"G Wegrzyn","year":"2004","unstructured":"Wegrzyn G, Wegrzyn A, Tylki-Szymanska A (2004) A general model for genetic regulation of turnover of glycosaminoglycans suggests a possible procedure for prediction of severity and clinical progress of mucopolysaccharidoses. Med Hypotheses 62:986\u2013992","journal-title":"Med Hypotheses"},{"key":"195_CR47","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1002\/ajmg.a.31831","volume":"143","author":"G Wegrzyn","year":"2007","unstructured":"Wegrzyn G, Tylki-Szymanska A, Liberek A et al (2007) Rapid deterioration of a patient with mucopolysaccharidosis type I during interruption of enzyme replacement therapy. Am J Med Genet A 143:1925\u20131927","journal-title":"Am J Med Genet A"},{"key":"195_CR48","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.mehy.2010.07.044","volume":"75","author":"G Wegrzyn","year":"2010","unstructured":"Wegrzyn G, Jakobkiewicz-Banecka J, Narajczyk M et al (2010) Why are behaviors of children suffering from various neuronopathic types of mucopolysaccharidoses different? Med Hypotheses 75:605\u2013609","journal-title":"Med Hypotheses"},{"key":"195_CR49","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/ajh.20504","volume":"80","author":"NJ Weinreb","year":"2005","unstructured":"Weinreb NJ, Barranger JA, Charrow J, Grabowski GA, Mankin HJ, Mistry P (2005) Guidance on the use of miglustat for treating patients with type 1 Gaucher disease. Am J Hematol 80:223\u2013229","journal-title":"Am J Hematol"},{"key":"195_CR50","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1651-2227.2008.00661.x","volume":"97","author":"JE Wraith","year":"2008","unstructured":"Wraith JE (2008) Enzyme replacement therapy with idursulfase in patients with mucopolysaccharidosis type II. Acta Paediatr Suppl 97:76\u201378","journal-title":"Acta Paediatr Suppl"}],"container-title":["Archivum Immunologiae et Therapiae Experimentalis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00005-012-0195-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00005-012-0195-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00005-012-0195-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,28]],"date-time":"2024-04-28T22:30:00Z","timestamp":1714343400000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00005-012-0195-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9,5]]},"references-count":50,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["195"],"URL":"https:\/\/doi.org\/10.1007\/s00005-012-0195-9","relation":{},"ISSN":["0004-069X","1661-4917"],"issn-type":[{"value":"0004-069X","type":"print"},{"value":"1661-4917","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,9,5]]}}}